Our Members
The Alliance for Connected Care aims to:
Demonstrate the importance of Connected Care as a tool for improved quality and efficiency.
Build significant and high-level support for Connected Care among leaders in Congress and the Administration.
Enable more telehealth to support new models of care.
Lift geographic and site restrictions for telehealth in Medicare.
Establish a consensus-based, standardized definition of Connected Care to advance with policymakers.
Alliance News
Alliance Coleads 300 Stakeholder Letter to Congressional Leaders
The Alliance for Connected Care co-led a letter, signed by almost 300 stakeholders, to Congressional leaders emphasizing the importance of preventing patient care disruptions by extending current telehealth flexibilities in an end-of-year package for a full year or more. Read the full letter here or below:
DRUG ENFORCEMENT ADMINISTRATION (DEA) RELEASES THIRD EXTENSION, ENSURING CERTAINTY AND ACCESS TO PATIENTS
FOR IMMEDIATE RELEASE MEDIA CONTACT Chris Adamec; cadamec@connectwithcare.org DRUG ENFORCEMENT ADMINISTRATION (DEA) RELEASES THIRD EXTENSION, ENSURING CERTAINTY AND ACCESS TO PATIENTS November 15, 2024 WASHINGTON DC – The Alliance for Connected Care applauds the third temporary extension of controlled substance prescribing via telemedicine rulemaking by the DEA. This one-year extension is an important step to ensure predictable access for patients, as requested by the Alliance for Connected Care and more than 300 other organizations earlier this year. “We are pleased to see the DEA act to ensure patient care is not interrupted next month,” said Chris Adamec, executive director of [...]
Alliance Letter to Congressional Leaders Continued Bipartisan Leadership for Access to Telehealth
The Alliance for Connected Care sent a letter to Congressional leaders requesting their continued bipartisan leadership in assuring the public that access to telehealth services will not be allowed to lapse on December 31. Read the full letter here or below:
Drug and Alcohol Dependence Journal: Factors Associated with Medications for Opioid Use Disorder (MOUD) Treatment Success During Pregnancy Periods
Drug and Alcohol Dependence Journal: Factors Associated with Medications for Opioid Use Disorder (MOUD) Treatment Success During Pregnancy Periods Medications for opioid use disorder (MOUD) are a crucial intervention for pregnant and postpartum individuals with opioid use disorder (OUD). This review evaluated factors associated with MOUD success during the pregnancy and postpartum period and found no differences in outcomes of individuals receiving telemedicine versus in-person care. These factors may help guide future research and inform the development and adaptation of interventions tailored to better meet the needs of this key population.
KFF: What to Know About Medicare Coverage of Telehealth
KFF: What to Know About Medicare Coverage of Telehealth Use of telehealth, which allows patients to see health care providers without being in the same location, has grown rapidly in recent years, among both privately-insured patients and Medicare beneficiaries. KFF released an issue brief, which provides answers to key questions about the current scope of Medicare telehealth coverage, including both temporary and permanent changes adopted through legislation and regulation, and policy considerations that lie ahead.